Basit öğe kaydını göster

dc.contributor.authorOK, ERCAN
dc.contributor.authorSever, Mehmet Sukru
dc.contributor.authorBasci, Ali
dc.contributor.authorArtan, Ayşe Serra
dc.contributor.authorOto, Özgür Akın
dc.contributor.authorYilmaz, Murvet
dc.contributor.authorKircelli, Fatih
dc.contributor.authorAŞCI, GÜLAY
dc.contributor.authorGunestepe, Kutay
dc.date.accessioned2021-03-05T08:17:01Z
dc.date.available2021-03-05T08:17:01Z
dc.date.issued2016
dc.identifier.citationYilmaz M., Kircelli F., Artan A. S. , Oto Ö. A. , AŞCI G., Gunestepe K., Basci A., OK E., Sever M. S. , "Naturally nonanemic dialysis patients: Who are they?", Hemodialysis international. International Symposium on Home Hemodialysis, cilt.20, ss.522-529, 2016
dc.identifier.issn1492-7535
dc.identifier.otherav_981afe04-48c6-4210-b40a-0026f7c679fa
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/102366
dc.identifier.urihttps://doi.org/10.1111/hdi.12425
dc.description.abstractIntroduction Not only anemia, but also erythropoiesis stimulating agent (ESA)s for treating anemia may adversely affect prognosis of chronic hemodialysis patients. Various features of naturally (with no ESA usage) nonanemic patients may be useful for defining several factors in the pathogenesis of anemia. Methods Data, retrieved from the European Clinical Database (EuCliD)-Turkey on naturally nonanemic prevalent chronic hemodialysis patients (n: 201) were compared with their anemic (those who required ESA treatment) counterparts (n: 3948). Findings Mean hemoglobin values were 13.5 +/- 0.8 and 11.5 +/- 0.9 g/dL in nonanemic and anemic patients, respectively (P < 0.001). Nonanemia status was associated with younger age, male gender, longer dialysis vintage, nondiabetic status, more frequent hepatitis-C virus seropositivity and more frequent arteriovenous fistula usage. Serum ferritin and CRP levels and urea reduction ratio were higher in ESA-requiring patients. One (99%) and two (95.3%) years survival rates of the "naturally nonanemic" patients were superior as compared to anemics (91.0% and 82.6%, respectively), (P < 0.001). Discussion "Naturally nonanemic" status is associated with better survival in prevalent chronic hemodialysis patients; underlying mechanisms in this favorable outcome should be investigated by randomized controlled trials including large number of patients.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectNefroloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleNaturally nonanemic dialysis patients: Who are they?
dc.typeMakale
dc.relation.journalHemodialysis international. International Symposium on Home Hemodialysis
dc.contributor.departmentBakirkoy Dr. Sadi Konuk Research & Training Hospital , ,
dc.identifier.volume20
dc.identifier.issue4
dc.identifier.startpage522
dc.identifier.endpage529
dc.contributor.firstauthorID235577


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster